Présentation
The present invention is directed to a dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection. The present invention provides means, in particular under the form of a composition or of a vaccine, for the prevention and/or treatment of a dengue virus infection.